Cancer Research, ISSN 0008-5472, 03/2007, Volume 67, Issue 6, pp. 2816 - 2823
Betulinic acid is a pentacyclic triterpene natural product initially identified as a melanoma-specific cytotoxic agent that exhibits low toxicity in animal...
PROXIMAL PROMOTER | NITRIC-OXIDE PRODUCTION | ONCOLOGY | NATURAL-PRODUCTS | PANCREATIC-CANCER | DRUG DISCOVERY | HUMAN-MELANOMA CELLS | DOWN-REGULATION | FACTOR EXPRESSION | 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID | SYNTHETIC OLEANANE | Prostatic Neoplasms - metabolism | Sp3 Transcription Factor - antagonists & inhibitors | Triterpenes - pharmacology | Microtubule-Associated Proteins - genetics | Apoptosis - drug effects | Microtubule-Associated Proteins - metabolism | Humans | Male | Sp1 Transcription Factor - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Promoter Regions, Genetic - drug effects | Sp1 Transcription Factor - antagonists & inhibitors | Liver - drug effects | Neoplasm Proteins - genetics | Prostatic Neoplasms - drug therapy | Sp3 Transcription Factor - metabolism | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - pathology | Inhibitor of Apoptosis Proteins | Cell Growth Processes - drug effects | Liver - metabolism | Sp3 Transcription Factor - genetics | Sp Transcription Factors - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Sp Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Proteasome Endopeptidase Complex - metabolism | Antineoplastic Agents, Phytogenic - pharmacology | Sp4 Transcription Factor - antagonists & inhibitors | Sp4 Transcription Factor - genetics
PROXIMAL PROMOTER | NITRIC-OXIDE PRODUCTION | ONCOLOGY | NATURAL-PRODUCTS | PANCREATIC-CANCER | DRUG DISCOVERY | HUMAN-MELANOMA CELLS | DOWN-REGULATION | FACTOR EXPRESSION | 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID | SYNTHETIC OLEANANE | Prostatic Neoplasms - metabolism | Sp3 Transcription Factor - antagonists & inhibitors | Triterpenes - pharmacology | Microtubule-Associated Proteins - genetics | Apoptosis - drug effects | Microtubule-Associated Proteins - metabolism | Humans | Male | Sp1 Transcription Factor - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Promoter Regions, Genetic - drug effects | Sp1 Transcription Factor - antagonists & inhibitors | Liver - drug effects | Neoplasm Proteins - genetics | Prostatic Neoplasms - drug therapy | Sp3 Transcription Factor - metabolism | Prostatic Neoplasms - blood supply | Prostatic Neoplasms - pathology | Inhibitor of Apoptosis Proteins | Cell Growth Processes - drug effects | Liver - metabolism | Sp3 Transcription Factor - genetics | Sp Transcription Factors - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Sp Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Proteasome Endopeptidase Complex - metabolism | Antineoplastic Agents, Phytogenic - pharmacology | Sp4 Transcription Factor - antagonists & inhibitors | Sp4 Transcription Factor - genetics
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 08/2015, Volume 152, pp. 111 - 124
Sp1 (specificity protein 1) is a well-known member of a family of transcription factors that also includes Sp2, Sp3 and Sp4, which are implicated in an ample...
Anticancer drugs | Transcription factors | Prognosis | Sp1 | Targeted therapy | Sp3 | PANCREATIC-CANCER | DOWN-REGULATION | FACTOR EXPRESSION | DNA-BINDING ACTIVITY | BREAST-CANCER | PHARMACOLOGY & PHARMACY | TOLFENAMIC ACID | NF-KAPPA-B | TUMOR-GROWTH | ENDOTHELIAL GROWTH-FACTOR | GENE-TRANSCRIPTION | Neoplasms - metabolism | Gene Targeting - methods | Promoter Regions, Genetic | Humans | Gene Expression Regulation, Neoplastic | Sp1 Transcription Factor - metabolism | Antineoplastic Agents - administration & dosage | Neoplasms - therapy | Animals | Neoplasms - genetics | Sp1 Transcription Factor - genetics | Binding Sites - physiology | Drug Delivery Systems - methods | Index Medicus
Anticancer drugs | Transcription factors | Prognosis | Sp1 | Targeted therapy | Sp3 | PANCREATIC-CANCER | DOWN-REGULATION | FACTOR EXPRESSION | DNA-BINDING ACTIVITY | BREAST-CANCER | PHARMACOLOGY & PHARMACY | TOLFENAMIC ACID | NF-KAPPA-B | TUMOR-GROWTH | ENDOTHELIAL GROWTH-FACTOR | GENE-TRANSCRIPTION | Neoplasms - metabolism | Gene Targeting - methods | Promoter Regions, Genetic | Humans | Gene Expression Regulation, Neoplastic | Sp1 Transcription Factor - metabolism | Antineoplastic Agents - administration & dosage | Neoplasms - therapy | Animals | Neoplasms - genetics | Sp1 Transcription Factor - genetics | Binding Sites - physiology | Drug Delivery Systems - methods | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e48208
Acetylsalicylic acid (aspirin) is highly effective for treating colon cancer patients postdiagnosis; however, the mechanisms of action of aspirin in colon...
SURVIVAL | ANGIOGENESIS | INDUCED APOPTOSIS | ACETYL SALICYLIC-ACID | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | IN-VIVO | FACTOR EXPRESSION | DEGRADATION | NF-KAPPA-B | ANTIINFLAMMATORY DRUGS | Colonic Neoplasms - genetics | Colonic Neoplasms - drug therapy | Humans | Sp3 Transcription Factor - genetics | Sp Transcription Factors - metabolism | Sp1 Transcription Factor - metabolism | Colonic Neoplasms - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Sp1 Transcription Factor - genetics | Mice, Nude | Female | Aspirin - therapeutic use | Cell Proliferation - drug effects | Mice | Sp Transcription Factors - genetics | Aspirin - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Gene Expression Regulation, Neoplastic - genetics | Sp3 Transcription Factor - metabolism | Sp4 Transcription Factor - genetics | Care and treatment | Aspirin | RNA | Growth | B cells | DNA binding proteins | Prevention | Colon cancer | Genetic research | Salicylates | Vascular endothelial growth factor | Apoptosis | Cancer | Tumors | Salts | Transcription factors | Bcl-2 protein | Genes | Colorectal cancer | Acetylsalicylic acid | Cyclin D1 | Anticancer properties | Proteins | β-catenin | Cell growth | Xenografts | Physiology | Inhibition | Colon | Salicylic acid | Immunoglobulins | RNA-mediated interference | Caspase | Pharmacology | Survivin | Gene expression | Metabolism | Sp1 protein | Zinc | Studies | Sodium salicylate | Acids | Ribonucleic acids | Sodium | Phenols | Antitumor activity | Sulfate | Zinc sulfate
SURVIVAL | ANGIOGENESIS | INDUCED APOPTOSIS | ACETYL SALICYLIC-ACID | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | IN-VIVO | FACTOR EXPRESSION | DEGRADATION | NF-KAPPA-B | ANTIINFLAMMATORY DRUGS | Colonic Neoplasms - genetics | Colonic Neoplasms - drug therapy | Humans | Sp3 Transcription Factor - genetics | Sp Transcription Factors - metabolism | Sp1 Transcription Factor - metabolism | Colonic Neoplasms - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Sp1 Transcription Factor - genetics | Mice, Nude | Female | Aspirin - therapeutic use | Cell Proliferation - drug effects | Mice | Sp Transcription Factors - genetics | Aspirin - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Gene Expression Regulation, Neoplastic - genetics | Sp3 Transcription Factor - metabolism | Sp4 Transcription Factor - genetics | Care and treatment | Aspirin | RNA | Growth | B cells | DNA binding proteins | Prevention | Colon cancer | Genetic research | Salicylates | Vascular endothelial growth factor | Apoptosis | Cancer | Tumors | Salts | Transcription factors | Bcl-2 protein | Genes | Colorectal cancer | Acetylsalicylic acid | Cyclin D1 | Anticancer properties | Proteins | β-catenin | Cell growth | Xenografts | Physiology | Inhibition | Colon | Salicylic acid | Immunoglobulins | RNA-mediated interference | Caspase | Pharmacology | Survivin | Gene expression | Metabolism | Sp1 protein | Zinc | Studies | Sodium salicylate | Acids | Ribonucleic acids | Sodium | Phenols | Antitumor activity | Sulfate | Zinc sulfate
Journal Article
Annals of Anatomy, ISSN 0940-9602, 2010, Volume 192, Issue 5, pp. 275 - 283
Sp1 and Sp3 are transcription factors expressed in all mammalian cells. These factors are involved in regulating the transcriptional activity of genes...
Sp1 | Sp3 and chromatin remodeling | DIHYDROPYRIMIDINE DEHYDROGENASE | ANATOMY & MORPHOLOGY | TRANSCRIPTION FACTOR SP1 | DOWN-REGULATION | HUMAN GASTRIC-CANCER | ELEMENT HALF-SITE | FACTOR-BINDING | ESTROGEN-RECEPTOR-ALPHA | GENE-EXPRESSION | HISTONE DEACETYLASE INHIBITORS | GROWTH-FACTOR EXPRESSION | Sp3 Transcription Factor - physiology | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | Chromatin Assembly and Disassembly | Sp1 Transcription Factor - chemistry | Sp1 Transcription Factor - metabolism | Sp3 Transcription Factor - chemistry | DNA-Binding Proteins - chemistry | DNA-Binding Proteins - metabolism | Transcription, Genetic | Sp1 Transcription Factor - physiology | Sp3 Transcription Factor - metabolism
Sp1 | Sp3 and chromatin remodeling | DIHYDROPYRIMIDINE DEHYDROGENASE | ANATOMY & MORPHOLOGY | TRANSCRIPTION FACTOR SP1 | DOWN-REGULATION | HUMAN GASTRIC-CANCER | ELEMENT HALF-SITE | FACTOR-BINDING | ESTROGEN-RECEPTOR-ALPHA | GENE-EXPRESSION | HISTONE DEACETYLASE INHIBITORS | GROWTH-FACTOR EXPRESSION | Sp3 Transcription Factor - physiology | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | Chromatin Assembly and Disassembly | Sp1 Transcription Factor - chemistry | Sp1 Transcription Factor - metabolism | Sp3 Transcription Factor - chemistry | DNA-Binding Proteins - chemistry | DNA-Binding Proteins - metabolism | Transcription, Genetic | Sp1 Transcription Factor - physiology | Sp3 Transcription Factor - metabolism
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 2008, Volume 372, Issue 1, pp. 1 - 13
Cell proliferation | Sp1 | SREBP-1 | Mediator | Smad | Tumorigenesis | Transcription factor | TAF4 | Synergism | p53 | RNA-POLYMERASE-II | transcription factor | DNA-BINDING DOMAIN | HISTONE DEACETYLASE INHIBITOR | cell proliferation | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION FACTOR SP1 | ACCELERATES TUMOR-FORMATION | COFACTOR COMPLEX CRSP | PROTEASOME-DEPENDENT DEGRADATION | BIOPHYSICS | synergism | tumorigenesis | mediator | C-MYC PROMOTER | NF-KAPPA-B | ENDOTHELIAL GROWTH-FACTOR | Cell Proliferation | Humans | Sp3 Transcription Factor - genetics | Transcriptional Activation | Sp1 Transcription Factor - metabolism | Animals | Sp1 Transcription Factor - genetics | Cell Transformation, Neoplastic - genetics | TATA Box | Burkitt Lymphoma - genetics | Huntington Disease - genetics | Mice | Protein Processing, Post-Translational | Sp1 Transcription Factor - physiology | Sp3 Transcription Factor - metabolism
Journal Article
Blood, ISSN 0006-4971, 2015, Volume 125, Issue 12, pp. 1957 - 1967
Sp1 and Sp3 belong to the specificity proteins (Sp)/Kruppel-like transcription factor family. They are closely related, ubiquitously expressed, and recognize...
LIGHT-CHAIN KINASE | INHERITED THROMBOCYTOPENIAS | FACTOR SP3 | MUTATION | MICE | HEMATOLOGY | PROPLATELET FORMATION | GATA1 | AGGREGATION | GPIB-IX-V | RUNX1 | Naphthalenes - chemistry | Signal Transduction | Sp3 Transcription Factor - genetics | Proteome | Sp1 Transcription Factor - metabolism | Thrombocytopenia - metabolism | Mice, Knockout | Platelet Aggregation | Transcription Factors - metabolism | Lectins, C-Type - metabolism | Animals | Flow Cytometry | Azepines - chemistry | Sp1 Transcription Factor - genetics | Spleen - metabolism | Blood Platelets - cytology | Blood Platelets - metabolism | Bone Marrow - metabolism | Platelet Membrane Glycoproteins - metabolism | Mice | Megakaryocytes - cytology | Sp3 Transcription Factor - metabolism
LIGHT-CHAIN KINASE | INHERITED THROMBOCYTOPENIAS | FACTOR SP3 | MUTATION | MICE | HEMATOLOGY | PROPLATELET FORMATION | GATA1 | AGGREGATION | GPIB-IX-V | RUNX1 | Naphthalenes - chemistry | Signal Transduction | Sp3 Transcription Factor - genetics | Proteome | Sp1 Transcription Factor - metabolism | Thrombocytopenia - metabolism | Mice, Knockout | Platelet Aggregation | Transcription Factors - metabolism | Lectins, C-Type - metabolism | Animals | Flow Cytometry | Azepines - chemistry | Sp1 Transcription Factor - genetics | Spleen - metabolism | Blood Platelets - cytology | Blood Platelets - metabolism | Bone Marrow - metabolism | Platelet Membrane Glycoproteins - metabolism | Mice | Megakaryocytes - cytology | Sp3 Transcription Factor - metabolism
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 10/2007, Volume 282, Issue 42, pp. 31038 - 31045
Methylglyoxal is a highly reactive dicarbonyl degradation product formed from triose phosphates during glycolysis. Methylglyoxal forms stable adducts primarily...
DIABETIC-RETINOPATHY | ACTIVATION | ADVANCED GLYCATION | SP1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | O-GLYCOSYLATION | MICE | 3 MAJOR PATHWAYS | EXPRESSION | HYPERGLYCEMIC DAMAGE | GLYOXALASE-I | Tumor Necrosis Factor-alpha - metabolism | Transcription, Genetic - drug effects | Kidney - pathology | Sweetening Agents - metabolism | Angiopoietin-2 - genetics | Protein Processing, Post-Translational - genetics | Diabetes Mellitus, Experimental - genetics | N-Acetylglucosaminyltransferases - genetics | Glycolysis - drug effects | Acetylglucosamine - metabolism | Glycolysis - genetics | Pyruvaldehyde - metabolism | Kidney - metabolism | Diabetic Angiopathies - pathology | Protein Processing, Post-Translational - drug effects | Arginine - genetics | Intercellular Adhesion Molecule-1 - biosynthesis | Vascular Cell Adhesion Molecule-1 - genetics | Response Elements - genetics | Diabetes Mellitus, Experimental - metabolism | Diabetic Angiopathies - genetics | Repressor Proteins - metabolism | Sp3 Transcription Factor - metabolism | Diabetic Angiopathies - metabolism | Sweetening Agents - pharmacology | Endothelial Cells - metabolism | Gene Expression Regulation - genetics | Sp3 Transcription Factor - genetics | Angiopoietin-2 - biosynthesis | Repressor Proteins - genetics | Glucose - pharmacology | Acetylglucosamine - genetics | N-Acetylglucosaminyltransferases - metabolism | Gene Expression Regulation - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Animals | Intercellular Adhesion Molecule-1 - genetics | Diabetes Mellitus, Experimental - pathology | Glucose - metabolism | Vascular Cell Adhesion Molecule-1 - biosynthesis | Mice | Endothelial Cells - pathology | Arginine - metabolism | Cell Line, Transformed
DIABETIC-RETINOPATHY | ACTIVATION | ADVANCED GLYCATION | SP1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | O-GLYCOSYLATION | MICE | 3 MAJOR PATHWAYS | EXPRESSION | HYPERGLYCEMIC DAMAGE | GLYOXALASE-I | Tumor Necrosis Factor-alpha - metabolism | Transcription, Genetic - drug effects | Kidney - pathology | Sweetening Agents - metabolism | Angiopoietin-2 - genetics | Protein Processing, Post-Translational - genetics | Diabetes Mellitus, Experimental - genetics | N-Acetylglucosaminyltransferases - genetics | Glycolysis - drug effects | Acetylglucosamine - metabolism | Glycolysis - genetics | Pyruvaldehyde - metabolism | Kidney - metabolism | Diabetic Angiopathies - pathology | Protein Processing, Post-Translational - drug effects | Arginine - genetics | Intercellular Adhesion Molecule-1 - biosynthesis | Vascular Cell Adhesion Molecule-1 - genetics | Response Elements - genetics | Diabetes Mellitus, Experimental - metabolism | Diabetic Angiopathies - genetics | Repressor Proteins - metabolism | Sp3 Transcription Factor - metabolism | Diabetic Angiopathies - metabolism | Sweetening Agents - pharmacology | Endothelial Cells - metabolism | Gene Expression Regulation - genetics | Sp3 Transcription Factor - genetics | Angiopoietin-2 - biosynthesis | Repressor Proteins - genetics | Glucose - pharmacology | Acetylglucosamine - genetics | N-Acetylglucosaminyltransferases - metabolism | Gene Expression Regulation - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Animals | Intercellular Adhesion Molecule-1 - genetics | Diabetes Mellitus, Experimental - pathology | Glucose - metabolism | Vascular Cell Adhesion Molecule-1 - biosynthesis | Mice | Endothelial Cells - pathology | Arginine - metabolism | Cell Line, Transformed
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 09/2015, Volume 14, Issue 9, pp. 2143 - 2153
The two major types of rhabdomyosarcoma (RMS) are predominantly diagnosed in children, namely embryonal (ERMS) and alveolar (ARMS) RMS, and patients are...
SURVIVAL | INVASION | CANCER CELL | INTERGROUP RHABDOMYOSARCOMA | ONCOLOGY | CURCUMIN | DOWN-REGULATION | MICRORNAS | FACTOR SP1 EXPRESSION | TUMOR-GROWTH | CHILDREN | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Down-Regulation | Humans | Rhabdomyosarcoma - metabolism | Sp1 Transcription Factor - metabolism | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Sp3 Transcription Factor - metabolism | Disease Models, Animal | HDAC inhibitors | cMyc | Sp transcription factors | ZBTBs | ROS
SURVIVAL | INVASION | CANCER CELL | INTERGROUP RHABDOMYOSARCOMA | ONCOLOGY | CURCUMIN | DOWN-REGULATION | MICRORNAS | FACTOR SP1 EXPRESSION | TUMOR-GROWTH | CHILDREN | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Down-Regulation | Humans | Rhabdomyosarcoma - metabolism | Sp1 Transcription Factor - metabolism | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Sp4 Transcription Factor - metabolism | Animals | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Sp3 Transcription Factor - metabolism | Disease Models, Animal | HDAC inhibitors | cMyc | Sp transcription factors | ZBTBs | ROS
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2012, Volume 287, Issue 5, pp. 3462 - 3478
Transcriptional mechanisms regulating type I collagen genes expression in physiopathological situations are not completely known. In this study, we have...
HEPATIC STELLATE CELLS | TGF-BETA | PROCOLLAGEN MESSENGER-RNA | BIOCHEMISTRY & MOLECULAR BIOLOGY | GROWTH-FACTOR BETA | BINDING SITES | NECROSIS-FACTOR-ALPHA | I COLLAGEN GENE | TNF-ALPHA | DEPENDENT MECHANISM | REPRESSES TRANSCRIPTION | Scleroderma, Localized - metabolism | Humans | Child, Preschool | Male | Sp1 Transcription Factor - metabolism | Transcription Factor RelA - genetics | DNA-Binding Proteins - metabolism | Collagen Type I - genetics | Adult | Transcription, Genetic | Child | Sp3 Transcription Factor - metabolism | Fibroblasts - metabolism | Dermis - metabolism | Response Elements | Gene Expression Regulation - genetics | Sp3 Transcription Factor - genetics | Scleroderma, Localized - pathology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Fibroblasts - pathology | Transcription Factors - metabolism | Collagen Type I - biosynthesis | Sp1 Transcription Factor - genetics | Transcription Factor RelA - metabolism | Dermis - pathology | Gene Regulation | Gene Transcription | Transcription Factors, Sp3, c-Krox | Sp1 | Collagen | Fibrosis | Type I Collagen | Skin | Scleroderma | Fibroblast | Nuclear Factor-κB
HEPATIC STELLATE CELLS | TGF-BETA | PROCOLLAGEN MESSENGER-RNA | BIOCHEMISTRY & MOLECULAR BIOLOGY | GROWTH-FACTOR BETA | BINDING SITES | NECROSIS-FACTOR-ALPHA | I COLLAGEN GENE | TNF-ALPHA | DEPENDENT MECHANISM | REPRESSES TRANSCRIPTION | Scleroderma, Localized - metabolism | Humans | Child, Preschool | Male | Sp1 Transcription Factor - metabolism | Transcription Factor RelA - genetics | DNA-Binding Proteins - metabolism | Collagen Type I - genetics | Adult | Transcription, Genetic | Child | Sp3 Transcription Factor - metabolism | Fibroblasts - metabolism | Dermis - metabolism | Response Elements | Gene Expression Regulation - genetics | Sp3 Transcription Factor - genetics | Scleroderma, Localized - pathology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Fibroblasts - pathology | Transcription Factors - metabolism | Collagen Type I - biosynthesis | Sp1 Transcription Factor - genetics | Transcription Factor RelA - metabolism | Dermis - pathology | Gene Regulation | Gene Transcription | Transcription Factors, Sp3, c-Krox | Sp1 | Collagen | Fibrosis | Type I Collagen | Skin | Scleroderma | Fibroblast | Nuclear Factor-κB
Journal Article
Cell Reports, ISSN 2211-1247, 08/2017, Volume 20, Issue 6, pp. 1319 - 1334
The histone deacetylase HDAC2, which negatively regulates synaptic gene expression and neuronal plasticity, is upregulated in Alzheimer’s disease (AD) patients...
memory | synaptic plasticity | Alzheimer’s disease | epigenetic | histone acetylation | Alzheimer's disease | HISTONE DEACETYLASE 2 | HIPPOCAMPUS | MEMORY | CHROMATIN | ALZHEIMERS-DISEASE | IN-VIVO | GENE-EXPRESSION | INHIBITORS | P25/CDK5 | PROMOTER | CELL BIOLOGY | Epigenesis, Genetic | Memory | Sp3 Transcription Factor - genetics | Male | Animals | Histones - genetics | Neuronal Plasticity | Alzheimer Disease - metabolism | Neurons - physiology | Female | Histone Code | Mice | Neurons - metabolism | Histone Deacetylase 2 - metabolism | Histones - metabolism | Sp3 Transcription Factor - metabolism
memory | synaptic plasticity | Alzheimer’s disease | epigenetic | histone acetylation | Alzheimer's disease | HISTONE DEACETYLASE 2 | HIPPOCAMPUS | MEMORY | CHROMATIN | ALZHEIMERS-DISEASE | IN-VIVO | GENE-EXPRESSION | INHIBITORS | P25/CDK5 | PROMOTER | CELL BIOLOGY | Epigenesis, Genetic | Memory | Sp3 Transcription Factor - genetics | Male | Animals | Histones - genetics | Neuronal Plasticity | Alzheimer Disease - metabolism | Neurons - physiology | Female | Histone Code | Mice | Neurons - metabolism | Histone Deacetylase 2 - metabolism | Histones - metabolism | Sp3 Transcription Factor - metabolism
Journal Article
Cell, ISSN 0092-8674, 07/2014, Volume 158, Issue 3, pp. 579 - 592
The p53 tumor suppressor coordinates a series of antiproliferative responses that restrict the expansion of malignant cells, and as a consequence, is lost or...
INTERMEDIATE-FILAMENT NESTIN | STEM-CELLS | INTRAHEPATIC CHOLANGIOCARCINOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | GROWTH | DEDIFFERENTIATION | MICE | DIFFERENTIATION | EXPRESSION | P53 | CELL BIOLOGY | Prognosis | Humans | Tumor Suppressor Protein p53 - metabolism | Sp1 Transcription Factor - metabolism | Hepatocytes - metabolism | Nestin - metabolism | Animals | Cell Transformation, Neoplastic | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Liver Neoplasms - pathology | Transcription, Genetic | Mice | Sp3 Transcription Factor - metabolism | Carcinoma, Hepatocellular - metabolism | Medical colleges | Liver cancer | Tumor proteins | Intermediate filament proteins
INTERMEDIATE-FILAMENT NESTIN | STEM-CELLS | INTRAHEPATIC CHOLANGIOCARCINOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | GROWTH | DEDIFFERENTIATION | MICE | DIFFERENTIATION | EXPRESSION | P53 | CELL BIOLOGY | Prognosis | Humans | Tumor Suppressor Protein p53 - metabolism | Sp1 Transcription Factor - metabolism | Hepatocytes - metabolism | Nestin - metabolism | Animals | Cell Transformation, Neoplastic | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Liver Neoplasms - pathology | Transcription, Genetic | Mice | Sp3 Transcription Factor - metabolism | Carcinoma, Hepatocellular - metabolism | Medical colleges | Liver cancer | Tumor proteins | Intermediate filament proteins
Journal Article